Cargando...
Using Functional Genomics to Overcome Therapeutic Resistance in Hematological Malignancies
Despite great advances in our understanding of the driving events involved in malignant transformation, only a small number of oncogenic drivers have been targeted and translated into tangible clinical benefit. Moreover, even when a targeted therapy can be shown to effectively inhibit an oncogenic d...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3673782/ https://ncbi.nlm.nih.gov/pubmed/22941562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12026-012-8353-z |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|